Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: A retrospective study

Publisher： Spandidos Publications

E-ISSN： 1791-2431|32|6|2619-2627

ISSN： 1021-335X

Source： Oncology Reports, Vol.32, Iss.6, 2014-01, pp. : 2619-2627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer

By Abrial Sophie   Penault-Llorca Frédérique   Delva Rémi   Bougnoux Philippe   Leduc Bernard   Mouret-Reynier Marie-Ange   Mery-Mignard Dominique   Bleuse Jean-Pierre   Dauplat Jacques   Curé Hervé   Chollet Philippe  

Breast Cancer Research and Treatment, Vol. 94, Iss. 3, 2005-12 ,pp. : 255-263

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy

By Falo Catalina   Moreno Abelardo   Varela Mar   Lloveras Belen   Figueras Agnès   Escobedo Agustín  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 7, 2007-07 ,pp. : 423-429

Springer Publishing Company

Access to resources Recommend Favorite

Site of primary tumor has a prognostic role in operable breast cancer: The International Breast Cancer Study Group experience

By Reed Valerie   Buchholz Thomas  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 117-119

Informa Healthcare

Access to resources Recommend Favorite

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

By Yardley Denise   Burris Howard   Peacock Nancy   Raefsky Eric   Melnik Marianne   Inhorn Roger   Shipley Dianna   Hainsworth John  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 471-475

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer - the role of clinical response

By Pierga J.-Y.   Mouret E.   Laurence V.   Dieras V.   Savigioni A.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Pouillart P.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1089-1096

Elsevier

Access to resources Recommend Favorite